Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.

Disqualifiers

Children under 8 years of age.

Patients who use an OPEP

Patients in the acute exacerbation phase of their DDB

Patients who are not under regular consultation

Trial design

Design model

Parallel

Treatments tested in this trial

  • adult questionnary for parents of children aged 8 to 13

    Other intervention

    Quality of life questionnaire for parents of children aged 8 to 13

  • Quality of life questionnaire for children aged 8 to 13

    Other intervention

    Quality of life questionnaire for children aged 8 to 13

  • Quality of life questionnaire for adolescents aged 14 to 17

    Other intervention

    Quality of life questionnaire for adolescents aged 14 to 17

  • Quality of life questionnaire for adults

    Other intervention

    Quality of life questionnaire for adults

  • A satisfaction adherence questionnaire

    Other intervention

    A satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Variation of patient quality of life before and after OPEP installation

quality of life is determined by qustionnaire

Time frame
18 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Universitaire, Amiens

Lead sponsor

Hôpital Armand Trousseau

Collaborator